Perspective Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-6.2M | $-4.7M | $-3.7M | $-6.0M | $-3.9M | $-3.5M | $-2.8M |
| Depreciation & Amortization | $68.0K | $471.0K | $576.0K | $685.4K | $739.1K | $847.1K | $888.6K |
| Depreciation | $68.0K | $471.0K | $576.4K | $685.4K | $739.1K | $847.1K | — |
| Amortization | $45.0K | $107.0K | $37.0K | $18.5K | $19.6K | $15.7K | — |
| Stock-Based Compensation | $372.0K | $290.0K | $205.0K | $186.0K | $108.4K | $173.3K | $242.7K |
| Net Cash from Operating Activities | $-5.7M | $-3.9M | $-3.5M | $-3.2M | $-3.1M | $-2.4M | $-2.4M |
| Investing Activities | |||||||
| Capital Expenditures | $549.0K | $479.0K | $133.0K | $19.0K | $6.6K | $55.1K | $137.5K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $1.5M | $8.8M | — | — | $-12.8K | $-95.5K | $-157.9K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-9.0K | $39.0K | — | — | $3.3M | $3.1M | $3.0M |
| Net Change in Cash | $-4.2M | $4.9M | $-2.5M | $4.8M | $227.2K | $560.5K | $433.4K |
| Free Cash Flow | $-6.3M | $-4.4M | $-3.7M | $-3.2M | $-3.1M | $-2.5M | $-2.6M |